Novartis Investigative Site

Xianyang, Shaanxi 712000

2 studies enrolling now · 3 studies all time

What they study most

Generalized Myasthenia Gravis, Primary Prevention of Atherosclerotic Cardiovascular Disease, Secondary Progressive Multiple Sclerosis (SPMS)

Studies at this site

• A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis — Recruiting now
• A Phase III Study to Investigate Efficacy, Safety and Tolerability of Iptacopan Compared With Placebo in Participants Aged 18 to 85 Years With gMG. — Recruiting now
• A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients. — Running, not enrolling